SHP2: a new target for pro‐senescence cancer therapies

M Serrano - The EMBO Journal, 2015 - embopress.org
… Right: Pharmacological inhibition of SHP2 (SHP2i) reactivates the senescence program, …
, we are still far from a detailed understanding of the signaling pathways controlled by SHP2

SHP2 Inhibition Abrogates MEK inhibitor Resistance in Multiple Cancer Models

C Fedele, H Ran, B Diskin, W Wei, J Jen, K Araki… - bioRxiv, 2018 - biorxiv.org
… Hence, our results suggest that SHP2 mediates RAS and ERK reactivation downstream of a
… effects of SHP2 modulation on other ERK pathway inhibitors. Prahallad et al. (14) found that …

Emerging chemical scaffolds with potential SHP2 phosphatase inhibitory capabilities–A comprehensive review

RKP Tripathi, SR Ayyannan - Chemical Biology & Drug Design, 2021 - Wiley Online Library
… , due to its critical role in various signalling pathways. Recently, few molecules with excellent
… specific SHP2 inhibitors are on purview. In this review, general aspects of SHP2 including …

Activating mutation of SHP2 establishes a tumorigenic phonotype through cell-autonomous and non-cell-autonomous mechanisms

L Dong, D Han, X Meng, M Xu, C Zheng… - Frontiers in Cell and …, 2021 - frontiersin.org
SHP2 inhibition by SHP099 in combination with sorafenib attenuated the adaptive … impeding
RTK-induced reactivation of the MEK/Erk and Akt signaling pathways. Dioscin inhibits MEK/…

WWP1 inhibition increases SHP2 inhibitor efficacy in colorectal cancer

H Fan, X Hu, F Cao, L Zhou, R Wen, H Shen… - NPJ Precision …, 2024 - nature.com
inhibition of WWP1 enhanced the effect of SHP2 inhibitor in … feedback reactivation of AKT
signaling following SHP2 inhibition. … reactivation of the AKT pathway following SHP2 inhibition. …

[HTML][HTML] SHP2 phosphatase as a novel therapeutic target for melanoma treatment

RY Zhang, ZH Yu, L Zeng, S Zhang, Y Bai, J Miao… - Oncotarget, 2016 - ncbi.nlm.nih.gov
pathways. We demonstrate that a specific SHP2 inhibitor 11a-1 [32] effectively suppresses
SHP2's … factor [48] or PDGFR [49], reactivate the signaling pathways which are mediated by …

PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells

F Liotti, N Kumar, N Prevete, M Marotta… - Journal of Experimental …, 2021 - Springer
Inhibitors targeting different proteins in this signalling cascade have been developed, but …
by adaptive feedback reactivation of the pathway [48]. Interestingly, SHP2 has been identified …

Shipping out MEK inhibitor resistance with SHP2 inhibitors

P Torres-Ayuso, J Brognard - Cancer discovery, 2018 - AACR
… on SHP2, and reactivation of downstream signals. Inhibition of both MEK and SHP2
abrogates MEK inhibitor–… Inhibitors of other cell signaling pathways are likely to synergize with …

[HTML][HTML] Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors

G Franciosa, JV Olsen - Oncotarget, 2023 - ncbi.nlm.nih.gov
… with inhibitors of other nodes of the RAS-ERK pathway [5]. … RTK responsible for SHP2
phosphorylation and reactivation. This … of SHP2 allosteric inhibitors and second generation FLT3 …

Overriding adaptive resistance to sorafenib via combination therapy with SHP2 blockade in hepatocellular carcinoma

CON Leung, M Tong, KPS Chung, L Zhou, N Che… - Hepatology, 2020 - hub.hku.hk
… In conclusion, SHP2 blockade by SHP099 in combination … reactivation of the MEK/ERK
and AKT signaling pathways. … Our results suggest that SHP2 inhibition could be a potential …